Women are being told about the opportunity to enroll in the trial when they schedule a routine mammogram.Once enrolled, they will be assigned to either 2-D or 3-D mammography screening.“The evolution of mammography technology provides us with an opportunity to fill in the gaps in our knowledge about two available breast cancer screening tests.” TMIST is comparing two types of digital mammography approved by the Food and Drug Administration: tomosynthesis (known as three-dimensional, or 3-D) and conventional (two-dimensional, or 2-D).Although 3-D mammography, being the newer technology, is likely to detect more findings that require follow-up, it is also likely to lead to more procedures and treatments.TMIST researchers intend to follow all participants for breast cancer status, treatment, and outcomes from the time of randomization until the end of the study (at least 2025).Based on the findings of earlier studies, researchers know that the vast majority of women in the study will not develop breast cancer.
Med Politikens e-avis kan du let danne dig et overblik over avisen og springe direkte til din favoritsektion.
Also draw attention to bonuses that give access to many XXX pay sites in different niches.
Our pay site reviews have hundreds of sex sites in 60 different porn categories.
” TMIST researchers are collecting data on the results of every mammogram, whether the imaging shows no signs of cancer, findings suspicious of cancer, or a breast cancer.
Any medical follow-ups, such as more imaging or biopsies, are also being reported.